Business
Research Programme in DNA Sequencing
Research Programme in DNA Sequencing.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 1276L NetScientific PLC 02 July 2014 \n \n\n \n \nNetScientific plc\n('NetScientific' or the 'Group')\nResearch Programme in DNA Sequencing\n \n \nNetScientific (AIM:NSCI), the biomedical and healthcare technology investment group, is pleased to announce that, to complement and reinforce its personalised medicine platform, Nanopore-II (a new US division of NetScientific) has secured an important research programme in DNA sequencing with a research institute in the United States.\n \nThis programme is in a fast-growing, valuable and very competitive field. Notwithstanding the crowded IP landscape, feedback from the US Patent Office on the initial filings is encouraging.\n \n \n\n\n\n\nFor further information, please contact\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNetScientific plc \n\n\nTel: +44 (0) 20 3590 8877\n\n\n\n\nFarad Azima, Chief Executive Officer\n\n\n\n\n\n\n\nPeter Thoms, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLiberum (Nomad & Broker) \n\n\nTel: +44 (0) 20 3100 2222\n\n\n\n\nChris Bowman / Christopher Britton / Thomas Bective\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBell Pottinger \n\n\nTel: +44 (0) 20 7861 3232\n\n\n\n\nDaniel de Belder\n\n\n\n\n\n\n\n \n \n \nCompany website: www.netscientific.net\n \n \nABOUT NETSCIENTIFIC\nNetScientific is a healthcare and life sciences company with global reach that funds and de...